Literature DB >> 1331244

A 15-year surveillance study of antibodies to herpes simplex virus types 1 and 2 in a cohort of young girls.

B Christenson1, M Böttiger, A Svensson, S Jeansson.   

Abstract

A cohort of 839 young girls at the ages of 14 and 15 years was screened for total antibodies to herpes simplex virus (HSV) and, if positive, for specific antibodies to HSV-2, by means of a sensitive, enzyme-linked immunosorbent assay (ELISA). The cohort was followed from 1972-1987. Blood samples were obtained on six occasions during these 16 years. In total, 2270 blood samples were taken. The number of sero-converting girls was studied in relation to calendar time. Two methods were constructed for the statistical analyses. The first of these gave an estimate of the sero-prevalence at different points in time. This analysis showed that the sero-prevalence which was 23% against HSV-1 in 1972 had increased to 36% in 1976. At the end of the study in 1987, 50% of the cohort had sero-converted against HSV-1. The proportion of girls who had sero-converted against HSV-2 was 0.4% in the 14-15-year-olds and had reached 22% by the end of the study. The second statistical method used all the available information implicit in the observations so as to obtain a maximum-likelihood (ML) estimate of the prevalence. The ML estimates were slightly more precise, but the two estimates did not differ significantly. The observations were further analysed by the Mantel-Haenszel test in order to see if there was any dependence between positivity to HSV-1 and HSV-2 respectively but none was found.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1331244     DOI: 10.1016/0163-4453(92)93943-k

Source DB:  PubMed          Journal:  J Infect        ISSN: 0163-4453            Impact factor:   6.072


  11 in total

1.  Comparative performance of herpes simplex virus type 1-specific serologic assays from MRL and Meridian Diagnostics.

Authors:  Julie A Ribes; Angela Smith; Marie Hayes; Doris J Baker; Jeffrey L Winters
Journal:  J Clin Microbiol       Date:  2002-03       Impact factor: 5.948

2.  Herpes simplex type 2 infection in a cohort aged 21 years.

Authors:  J Eberhart-Phillips; N P Dickson; C Paul; J P Fawcett; D Holland; J Taylor; A L Cunningham
Journal:  Sex Transm Infect       Date:  1998-06       Impact factor: 3.519

3.  Risk of herpes simplex virus type 2 acquisition increases over early adulthood: evidence from a cohort study.

Authors:  N Dickson; T van Roode; P Herbison; J Taylor; A Cunningham; C Paul
Journal:  Sex Transm Infect       Date:  2006-08-17       Impact factor: 3.519

4.  Serological evaluation of herpes simplex virus type 1 and type 2 infections in pregnancy.

Authors:  M Arvaja; M Lehtinen; P Koskela; M Lappalainen; J Paavonen; T Vesikari
Journal:  Sex Transm Infect       Date:  1999-06       Impact factor: 3.519

5.  Use of antiviral treatment and prophylaxis is unlikely to have a major impact on the prevalence of herpes simplex virus type 2.

Authors:  P J White; G P Garnett
Journal:  Sex Transm Infect       Date:  1999-02       Impact factor: 3.519

6.  Six-year study of the incidence of herpes in genital and nongenital cultures in a central Kentucky medical center patient population.

Authors:  J A Ribes; A D Steele; J P Seabolt; D J Baker
Journal:  J Clin Microbiol       Date:  2001-09       Impact factor: 5.948

7.  Rising incidence and prevalence of herpes simplex type 2 infection in a cohort of 26 year old New Zealanders.

Authors:  J E Eberhart-Phillips; N P Dickson; C Paul; G P Herbison; J Taylor; A L Cunningham
Journal:  Sex Transm Infect       Date:  2001-10       Impact factor: 3.519

8.  Predominance of herpes simplex virus type 1 from patients with genital herpes in Nova Scotia.

Authors:  Kevin R Forward; Spencer Hs Lee
Journal:  Can J Infect Dis       Date:  2003-03

Review 9.  Genital herpes: review of the epidemic and potential use of type-specific serology.

Authors:  R L Ashley; A Wald
Journal:  Clin Microbiol Rev       Date:  1999-01       Impact factor: 26.132

10.  The seroepidemiology of herpes simplex virus type 1 and 2 in Europe.

Authors:  R G Pebody; N Andrews; D Brown; R Gopal; H De Melker; G François; N Gatcheva; W Hellenbrand; S Jokinen; I Klavs; M Kojouharova; T Kortbeek; B Kriz; K Prosenc; K Roubalova; P Teocharov; W Thierfelder; M Valle; P Van Damme; R Vranckx
Journal:  Sex Transm Infect       Date:  2004-06       Impact factor: 3.519

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.